Back to mobile site

UBS Reiterates Buy Rating on Ardent Health Partners Inc (ARDT)

September 23, 2025 8:55 AM EDT Send to a Friend
UBS analyst AJ Rice reiterated a Buy rating and $17.00 price target on Ardent Health Partners Inc (NYSE: ARDT).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login